product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-AMPA Receptor (GluR 2) (Tyr869/Tyr873/Tyr876) Antibody
catalog :
3921
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 1
Published Application/Species/Sample/DilutionReference
  • western blot; rat; fig 3
Jang S, Royston S, Lee G, Wang S, Chung H. Seizure-Induced Regulations of Amyloid-?, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity. Neural Plast. 2016;2016:2123748 pubmed publisher
product information
SKU :
3921S
Product-Name :
Phospho-AMPA Receptor (GluR 2) (Tyr869/Tyr873/Tyr876) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
R, (H, M)
Applications :
Western blot
Product-Category :
Neuroscience
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
100
Host :
Rabbit
Target :
GluR2 (Tyr869/Tyr873/Tyr876) phosphate
Primary-Protein :
GluR2
Alt-Names :
AMPA-selective glutamate receptor 2,GLUR2,GLURB,GRIA2,GluR-2,GluR-B,GluR-K2,Glutamate receptor 2,Glutamate receptor ionotropic, AMPA 2,HBGR2,glutamate receptor, ionotropic, AMPA 2
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.